Literature DB >> 9370050

Cholinergic activity and amyloid precursor protein metabolism.

M R Roberson1, L E Harrell.   

Abstract

With more than 4 million Alzheimer's victims nationwide, there is intense research to elucidate the relationship among the hallmarks of the disease, amyloid plaques, neurofibrillary tangles, and degeneration of the basal forebrain cholinergic neurons. There has been much debate about which of these is the primary lesion, and which develops secondarily. The correlation between plaques and tangles and dementia is not absolute, but a consistent feature of Alzheimer's disease is loss of cortical and hippocampal cholinergic function as a result of basal forebrain compromise. Additionally, factors associated with the cholinergic system have been shown to influence the processing and metabolism of the amyloid precursor, a protein that contains the amyloidogenic sequence found in plaques. In this paper, the relationship between cholinergic compromise and amyloid deposition, as well as the cholinergic system-associated factors which appear to participate in amyloid precursor protein processing, are discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9370050     DOI: 10.1016/s0165-0173(97)00016-7

Source DB:  PubMed          Journal:  Brain Res Brain Res Rev


  19 in total

1.  Cognitive changes and modified processing of amyloid precursor protein in the cortical and hippocampal system after cholinergic synapse loss and muscarinic receptor activation.

Authors:  L Lin; B Georgievska; A Mattsson; O Isacson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

2.  Fetal Alz-50 clone 1, a novel zinc finger protein, binds a specific DNA sequence and acts as a transcriptional regulator.

Authors:  K L Jordan-Sciutto; J M Dragich; J L Rhodes; R Bowser
Journal:  J Biol Chem       Date:  1999-12-03       Impact factor: 5.157

3.  The M1 muscarinic agonist CI-1017 facilitates trace eyeblink conditioning in aging rabbits and increases the excitability of CA1 pyramidal neurons.

Authors:  C Weiss; A R Preston; M M Oh; R D Schwarz; D Welty; J F Disterhoft
Journal:  J Neurosci       Date:  2000-01-15       Impact factor: 6.167

4.  Cholinergic septo-hippocampal innervation is required for trace eyeblink classical conditioning.

Authors:  Angela Fontán-Lozano; Julieta Troncoso; Alejandro Múnera; Angel Manuel Carrión; José María Delgado-García
Journal:  Learn Mem       Date:  2005-11-14       Impact factor: 2.460

5.  GRK5 deficiency accelerates {beta}-amyloid accumulation in Tg2576 mice via impaired cholinergic activity.

Authors:  Shaowu Cheng; Longxuan Li; Shuangteng He; Jun Liu; Yuning Sun; Minchao He; Kenneth Grasing; Richard T Premont; William Z Suo
Journal:  J Biol Chem       Date:  2010-11-01       Impact factor: 5.157

6.  Phenserine regulates translation of beta -amyloid precursor protein mRNA by a putative interleukin-1 responsive element, a target for drug development.

Authors:  K T Shaw; T Utsuki; J Rogers; Q S Yu; K Sambamurti; A Brossi; Y W Ge; D K Lahiri; N H Greig
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-12       Impact factor: 11.205

Review 7.  Glutamate system, amyloid ß peptides and tau protein: functional interrelationships and relevance to Alzheimer disease pathology.

Authors:  Timothy J Revett; Glen B Baker; Jack Jhamandas; Satyabrata Kar
Journal:  J Psychiatry Neurosci       Date:  2013-01       Impact factor: 6.186

8.  Rapid β-amyloid deposition and cognitive impairment after cholinergic denervation in APP/PS1 mice.

Authors:  Juan Jose Ramos-Rodriguez; Mar Pacheco-Herrero; Diana Thyssen; Maria Isabel Murillo-Carretero; Esther Berrocoso; Tara L Spires-Jones; Brian J Bacskai; Monica Garcia-Alloza
Journal:  J Neuropathol Exp Neurol       Date:  2013-04       Impact factor: 3.685

Review 9.  Role of cholesterol in APP metabolism and its significance in Alzheimer's disease pathogenesis.

Authors:  M Maulik; D Westaway; J H Jhamandas; S Kar
Journal:  Mol Neurobiol       Date:  2012-09-16       Impact factor: 5.590

Review 10.  Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment.

Authors:  D Allan Butterfield; Tanea Reed; Shelley F Newman; Rukhsana Sultana
Journal:  Free Radic Biol Med       Date:  2007-06-13       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.